Finance

Beta
Lists
HESTERBIO:NSE
Hester Biosciences Ltd
₹1,920.00
-2.20%
(-43.20) 1D
Jun 9, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for HESTERBIO...
Open
₹1,941.00
High
₹1,970.00
Low
₹1,916.00
Mkt. cap
16.33B
Avg. vol.
19.12K
Volume
8.80K
P/E ratio
28.41
52-wk high
₹2,350.00
52-wk low
₹1,239.30
EPS
₹67.57
Shares outstanding
8.51M
No. of employees
562
Open
₹1,941.00
High
₹1,970.00
Low
₹1,916.00
Mkt. cap
16.33B
Avg. vol.
19.12K
Volume
8.80K
P/E ratio
28.41
52-wk high
₹2,350.00
52-wk low
₹1,239.30
EPS
₹67.57
Shares outstanding
8.51M
No. of employees
562
News stories
From sources across the web
Profile
Hester Biosciences Limited is a publicly traded Indian animal and poultry vaccines manufacturing company, headquartered in Ahmedabad. Hester has plants situated in Gujarat and Nepal. Hester has a 30% share of the poultry vaccines market in India, making it the country's second largest poultry vaccine manufacturer. Hester is also the first commercial manufacturer of goat pox vaccine in India and manufactures PPR vaccines from both, Nigerian and Sungri strains. Wikipedia
About Hester Biosciences Ltd
CEO-
Employees562
Founded1983
Headquarters-
SectorBiotechnology
Websitehester.in
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
841.05M
709.69M
774.15M
1.00B
Cost of goods sold
224.62M
193.19M
207.28M
194.50M
Cost of revenue
224.62M
193.19M
207.28M
194.50M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
152.82M
155.01M
155.18M
163.66M
Operating expense
430.11M
442.86M
433.25M
522.42M
Total operating expenses
654.73M
636.05M
640.53M
716.92M
Operating income
186.32M
73.64M
133.62M
284.18M
Other non operating income
23.16M
97.27M
6.69M
-30.28M
EBT including unusual items
201.87M
170.36M
135.24M
250.88M
EBT excluding unusual items
201.87M
170.36M
135.24M
221.52M
Income tax expense
28.91M
27.05M
42.14M
85.42M
Effective tax rate
14.32%
15.88%
31.16%
34.05%
Other operating expenses
235.47M
244.31M
233.76M
299.62M
Net income
164.42M
144.49M
87.65M
159.82M
Net profit margin
19.55%
20.36%
11.32%
15.96%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-18.10M
-22.07M
-18.22M
-50.95M
Net interest expenses
-18.10M
-22.07M
-18.22M
-50.95M
Depreciation and amortization charges
41.82M
43.54M
44.31M
59.14M
EBITDA
227.36M
116.32M
174.66M
331.38M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more